Cargando…
凝血酶原复合物联合小剂量利妥昔单抗治疗血友病B伴抑制物
OBJECTIVE: To explore the immune tolerance induction (ITI) in a case of severe hemophilia B patient with inhibitor. METHODS: The F Ⅸ∶C was detected using a one-stage method and FIX inhibitor was assayed using Bethesda method. ITI was performed with prothrombin complex concentrates (PCC) in combinati...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348358/ https://www.ncbi.nlm.nih.gov/pubmed/29081190 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.09.004 |
Ejemplares similares
-
重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
Publicado: (2020) -
血友病A患儿凝血因子Ⅷ抑制物相关临床研究
Publicado: (2020) -
血友病A抑制物研究进展
Publicado: (2017) -
伴有抑制物儿童血友病的免疫耐受诱导策略
Publicado: (2018) -
小剂量利妥昔单抗治疗12例难治/复发原发性自身免疫性溶血性贫血患者疗效分析
Publicado: (2017)